The foundation:

• López-Otín C. et al. (2013) The hallmarks of aging. Cell 153:1194-1217
  
• Kennedy BK. et al. (2014) Geroscience: linking aging to chronic disease. Cell 159:709-713
• Kohanski R. et al. (2016) Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health? Ann N Y Acad Sci. 1386: 30-44.
  

Geroscience:

• Sierra F. and Kohanski R. (2013) Geroscience offers a new model for investigating the links between aging biology and susceptibility to aging-related chronic diseases. Public Policy & Aging Report 23:7-11.
• Sierra F. and Kohanski R. (2017) Geroscience and the trans-NIH Geroscience Interest Group, GSIG. Geroscience 39:1-5.
  

Special issue of J. Gerontology 71 (11): 1385-1434. Includes the following articles:

• Sierra F. – Moving geroscience into uncharted waters. pp. 1385-1387.
• Burd C. et al. – Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms. pp. 388-1394.
  
• Huffman D. et al. – Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience. pp. 1395-1406.
  
• Kirkland J. et al. – Resilience in aging mice. pp. 1407-1414.
  
• Justice J. et al.: Frameworks for proof-of-concept clinical trials of interventions that target fundamental aging processes. pp.1415-1423.
  
• Newman J. et al. – Strategies and challenges in clinical trials targeting human aging. pp. 1424-1434.

Current status of translational concepts:

Special issue of JAMA 320 (13): 1319-1324. Includes the following articles:

• Tchkonia T. and Kirkland J. – Aging, Cell Senescence, and Chronic Disease. Emerging Therapeutic Strategies. pp. 1319-1320.
• Barzilai N., Cuervo AM. and Austad S. – Aging as a biological target for prevention and therapy. pp. 1321-1322.
• Olshansky J. – From lifespan to healthspan. pp. 1323-1324.